Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Targeting TNF-alpha inhibits endotoxin-induced airways' neutrophilia in humans

March 28, 2011

Pentoxifylline improves erectile function following cavernous nerve injury in rats

March 28, 2011

TRPM8 antagonists show potential for treating overactive bladder

March 28, 2011

Phase III study results detailed for abiraterone acetate in metastatic CRPC

March 25, 2011

Results from phase I/II trial of MDV-3100 in CRPC reveal long-term efficacy

March 25, 2011

Two phase III studies demonstrate the efficacy of mirabegron in overactive bladder

March 25, 2011

Levels of Kit ligand in the serum described as possible biomarker for AIU

March 25, 2011

Potential new biomarker for chronic rhinosinusitis with nasal polyps identified / News in Context

March 24, 2011

Efficacy of botulinum toxin type A in idiopathic detrusor overactivity confirmed in large study

March 24, 2011

Theravida's THVD-201 reduces symptoms of dry mouth in phase I trial in OAB, phase II study under way

March 24, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...